299 related articles for article (PubMed ID: 19281745)
1. Atypical Alport syndrome associated with a novel COL4A5 mutation.
Höpker K; Liebau MC; Friederichsohn C; Waldherr R; Benzing T
Clin Nephrol; 2009 Mar; 71(3):321-5. PubMed ID: 19281745
[TBL] [Abstract][Full Text] [Related]
2.
Zhang P; Zhuo L; Zou Y; Li G; Peng K
Clin Nephrol; 2019 Aug; 92(2):98-102. PubMed ID: 31198170
[No Abstract] [Full Text] [Related]
3. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
Wilson JC; Yoon HS; Walker RJ; Eccles MR
Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
[TBL] [Abstract][Full Text] [Related]
4. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
5. A Novel Mutation in a Kazakh Family with X-Linked Alport Syndrome.
Baikara BT; Zholdybayeva EV; Rakhimova SE; Nigmatullina NB; Momynaliev KT; Ramanculov YM
PLoS One; 2015; 10(7):e0132010. PubMed ID: 26168235
[TBL] [Abstract][Full Text] [Related]
6. Linkage analysis and a novel COL4A5 mutation in a large Turkish family with Alport syndrome.
Tug E; Percin FE; Pala E; Baysoy G
Genet Couns; 2011; 22(2):143-53. PubMed ID: 21848006
[TBL] [Abstract][Full Text] [Related]
7. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
Malone AF; Funk SD; Alhamad T; Miner JH
Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
[TBL] [Abstract][Full Text] [Related]
8. Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome.
Helle OMB; Pedersen TH; Ousager LB; Thomassen M; Hertz JM
Mol Genet Genomic Med; 2020 Oct; 8(10):e1452. PubMed ID: 32812400
[TBL] [Abstract][Full Text] [Related]
9. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
10. X-Linked Glomerulopathy Due to COL4A5 Founder Variant.
Barua M; John R; Stella L; Li W; Roslin NM; Sharif B; Hack S; Lajoie-Starkell G; Schwaderer AL; Becknell B; Wuttke M; Köttgen A; Cattran D; Paterson AD; Pei Y
Am J Kidney Dis; 2018 Mar; 71(3):441-445. PubMed ID: 29198386
[TBL] [Abstract][Full Text] [Related]
11. Kidney Injury by Variants in the
Frese J; Kettwig M; Zappel H; Hofer J; Gröne HJ; Nagel M; Sunder-Plassmann G; Kain R; Neuweiler J; Gross O
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691124
[TBL] [Abstract][Full Text] [Related]
12. Mutation c.359_363delGTATTinsATAC in the COL4A5 causes Alport syndrome in a Chinese family.
Wang Q; Liu F; Xing Y; Wei X; Li H; Zhang S; Liu J; Wang Q; Tang Z; Liu M
Gene; 2013 Jan; 512(2):482-5. PubMed ID: 23085274
[TBL] [Abstract][Full Text] [Related]
13. A COL4A5 Missense Variant in a Han-Chinese Family with X-linked Alport Syndrome.
Wu Y; Guo Y; Yuan J; Xu H; Chen Y; Zhang H; Yuan M; Deng H; Yuan L
Curr Mol Med; 2019; 19(10):758-765. PubMed ID: 31490752
[TBL] [Abstract][Full Text] [Related]
14. Targeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of Alport syndrome or proteinuria.
Chatterjee R; Hoffman M; Cliften P; Seshan S; Liapis H; Jain S
PLoS One; 2013; 8(10):e76360. PubMed ID: 24130771
[TBL] [Abstract][Full Text] [Related]
15. COL4A4-related nephropathy caused by a novel mutation in a large consanguineous Saudi family.
Ramzan K; Imtiaz F; Taibah K; Alnufiee S; Akhtar M; Al-Hazzaa SA; Al-Owain M
Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):427-32. PubMed ID: 24398087
[TBL] [Abstract][Full Text] [Related]
16. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
[TBL] [Abstract][Full Text] [Related]
17. Identification of a new mutation in the alpha4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemia.
Ciccarese M; Casu D; Ki Wong F; Faedda R; Arvidsson S; Tonolo G; Luthman H; Satta A
Nephrol Dial Transplant; 2001 Oct; 16(10):2008-12. PubMed ID: 11572889
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel COL4A5 mutation in the proband initially diagnosed as IgAN from a Chinese family with X-linked Alport syndrome.
Li Z; Zhu P; Huang H; Pan Y; Han P; Cui H; Kang Z; Xun M; Zhang Y; Liu S; Wang J; Wu J
Sci China Life Sci; 2019 Dec; 62(12):1572-1579. PubMed ID: 31209800
[TBL] [Abstract][Full Text] [Related]
19. A new mutation in the COL4A3 gene responsible for autosomal dominant Alport syndrome, which only generates hearing loss in some carriers.
Rosado C; Bueno E; Fraile P; García-Cosmes P; González-Sarmiento R
Eur J Med Genet; 2015 Jan; 58(1):35-8. PubMed ID: 25450602
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the 5'exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome.
Sá MJ; Fieremans N; de Brouwer AP; Sousa R; e Costa FT; Brito MJ; Carvalho F; Rodrigues M; de Sousa FT; Felgueiras J; Neves F; Carvalho A; Ramos U; Vizcaíno JR; Alves S; Carvalho F; Froyen G; Oliveira JP
J Med Genet; 2013 Nov; 50(11):745-53. PubMed ID: 23958657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
